Literature DB >> 19703422

Identification of soluble WSX-1 not as a dominant-negative but as an alternative functional subunit of a receptor for an anti-Alzheimer's disease rescue factor Humanin.

Yuichi Hashimoto1, Megumi Kurita, Masaaki Matsuoka.   

Abstract

Humanin (HN) inhibits Alzheimer's disease (AD)-relevant neuronal death and dysfunction, by interacting with a receptor (s) involving ciliary neurotrophic factor receptor alpha (CNTFR), WSX-1, and gp130. It remains unknown whether this complex is the sole HN receptor that mediates HN-induced anti-AD activity. We here report that an alternatively spliced WSX-1 isoform, encoding an extracellular 270-amino-acid region of WSX-1 with cytokine-binding regions (named soluble WSX-1; sWSX-1), is expressed in neuronal cells lacking function of full-length WSX-1 and enables HN to rescue AD-relevant death. This result suggests that CNTFR/soluble WSX-1/gp130 behaves as an alternative functional HN receptor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19703422     DOI: 10.1016/j.bbrc.2009.08.095

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  The Mitochondria-Derived Peptide Humanin Improves Recovery from Intracerebral Hemorrhage: Implication of Mitochondria Transfer and Microglia Phenotype Change.

Authors:  Joo Eun Jung; Guanghua Sun; Jesus Bautista Garrido; Lidiya Obertas; Alexis S Mobley; Shun-Ming Ting; Xiurong Zhao; Jaroslaw Aronowski
Journal:  J Neurosci       Date:  2020-01-24       Impact factor: 6.167

Review 2.  Function of alternative splicing.

Authors:  Olga Kelemen; Paolo Convertini; Zhaiyi Zhang; Yuan Wen; Manli Shen; Marina Falaleeva; Stefan Stamm
Journal:  Gene       Date:  2012-08-15       Impact factor: 3.688

Review 3.  Peptides derived from small mitochondrial open reading frames: Genomic, biological, and therapeutic implications.

Authors:  Brendan Miller; Su-Jeong Kim; Hiroshi Kumagai; Hemal H Mehta; Wang Xiang; Jiali Liu; Kelvin Yen; Pinchas Cohen
Journal:  Exp Cell Res       Date:  2020-05-06       Impact factor: 3.905

Review 4.  Humanin and the receptors for humanin.

Authors:  Masaaki Matsuoka; Yuichi Hashimoto
Journal:  Mol Neurobiol       Date:  2009-12-09       Impact factor: 5.590

5.  The Potent Humanin Analogue (HNG) Protects Germ Cells and Leucocytes While Enhancing Chemotherapy-Induced Suppression of Cancer Metastases in Male Mice.

Authors:  YanHe Lue; Ronald Swerdloff; Junxiang Wan; Jialin Xiao; Samuel French; Vince Atienza; Victor Canela; Kevin W Bruhn; Brian Stone; Yue Jia; Pinchas Cohen; Christina Wang
Journal:  Endocrinology       Date:  2015-09-18       Impact factor: 4.736

Review 6.  Protective effects of Humanin and calmodulin-like skin protein in Alzheimer's disease and broad range of abnormalities.

Authors:  Masaaki Matsuoka
Journal:  Mol Neurobiol       Date:  2014-06-27       Impact factor: 5.590

7.  SH3-binding protein 5 mediates the neuroprotective effect of the secreted bioactive peptide humanin by inhibiting c-Jun NH2-terminal kinase.

Authors:  Yuji Takeshita; Yuichi Hashimoto; Mikiro Nawa; Hiroyuki Uchino; Masaaki Matsuoka
Journal:  J Biol Chem       Date:  2013-07-16       Impact factor: 5.157

8.  The IL-27 component EBI-3 and its receptor subunit IL-27Rα are essential for the cytoprotective action of humanin on male germ cells†.

Authors:  Yue Jia; Ronald S Swerdloff; YanHe Lue; Jenny Dai-Ju; Prasanth Surampudi; Pinchas Cohen; Christina Wang
Journal:  Biol Reprod       Date:  2021-03-11       Impact factor: 4.161

9.  Secreted calmodulin-like skin protein inhibits neuronal death in cell-based Alzheimer's disease models via the heterotrimeric Humanin receptor.

Authors:  Y Hashimoto; M Nawa; M Kurita; M Tokizawa; A Iwamatsu; M Matsuoka
Journal:  Cell Death Dis       Date:  2013-03-21       Impact factor: 8.469

10.  The Mitochondrial-Derived Peptide Humanin Protects RPE Cells From Oxidative Stress, Senescence, and Mitochondrial Dysfunction.

Authors:  Parameswaran G Sreekumar; Keijiro Ishikawa; Chris Spee; Hemal H Mehta; Junxiang Wan; Kelvin Yen; Pinchas Cohen; Ram Kannan; David R Hinton
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-03       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.